Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions: A Large DAPROCA Randomised Trial.

NCT07343349 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT07343349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07343349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions: A Large DAPROCA Randomised Trial.
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Recruiting
Start date
December 15, 2025
Completion date
October 30, 2040
Enrollment
1,016 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

high risk localised prostate carcinoma, locally advanced prostate cancer, prostate cancer patients undergoing external radiation and seed implantation, unfavourable intermediate risk prostate cancer